No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
NeuroScientific Biopharmaceuticals Secures AU$2 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%
Neuroscientific Biopharmaceuticals (ASX:NSB) secured a AU$2.2 million rebate from the Australian government research and development tax incentive scheme for the fiscal year ended June 30, 2023, accor
NeuroScientific Biopharmaceuticals Limited's (ASX:NSB) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
NeuroScientific Biopharmaceuticals (ASX:NSB) Secures $3.7m Tax Incentive Refund
No Data